4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-19-000038
Chief Commercial Officer bought 3,064 shares at $2.85 ($8,725)
From the SEC's structured data for this filing
Trades in this filing
Harrell James Archie Jr · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-10 | Purchase : show line 1 in the form | +3,064 | $2.85 | $8,725 | 11,618 | D |
| Open-market purchases · 3,064 sh · avg $2.85 · $8,725 | ||||||
Loading xslF345X03/primary_doc.xml…